Sign in
or Register nowSchizophreniaConnection.com
What Is The Drug Classification Of Abilify
Health Encyclopedia: Schizophrenia Introduction
- Schizophrenia - Introduction
- Introduction
- Causes
- Risk Factors
- Common Symptoms
- Complications
- Diagnosis
Highlights
Drug Approvals
- In 2007, the Food and Drug Administration approved risperidone (Risperdal) and aripiprazole (Abilify) for treatment schizophrenia in teenagers. These drugs are the first atypical antipsychotics approved specifically for children.
- Paliperidone (Invega) is the newest atypical antipsychotic drug approved for treatment of schizophrenia in adults. Paliperidone is chemically related to risperidone.
Diabetes Risk and Atypical Antipsychotics
- In 2007, the manufacturer of olanzapine (...
Expert & Community Posts
Rethinking Antipsychotics - Part I
By John McManamy , Health Expert...1990s - Risperdal, Zyprexa, and Seroquel. Geodon and Abilify followed in the early 2000s. Invega... Read more »
Health Guide
Bipolar Medications
...antipsychotic), olanzapine (Zyprexa), risperidone (Risperdal), quetiapine (Seroquel), aripiprazole (Abilify) and ziprasidone (Geodon).Olanzapine was the first atypical antipsychotic approved for... Read more »Bipolar Disorder Treatment
...olanzapine (Zyprexa), risperidone (Risperdal), quetiapine (Seroquel), ziprasidone (Geodon), and ariprazole (Abilify). These five drugs have all been approved for treatment of bipolar mania and,... Read more »Schizophrenia: Treatment
...risperidone (Risperdal), olanzapine (Zyprexa), quetiapine (Seroquel), ziprasidone (Geodon), aripiprazole (Abilify), and palperidone (Invega).Which Type of Drug to Choose. Experts have debated... Read more »Schizophrenia: Treatment
...States:Clozapine (Clozaril)Risperidone (Risperdal)Olanzapine (Zyprexa)Quetiapine (Seroquel)Aripiprazole (Abilify)Ziprasidone (Geodon)Paliperidone (Invega)Clozapine was the first atypical drug... Read more »Non-Small Cell Lung Cancer: References
ReferencesU.S. Food and Drugs Administration. Alert for Healthcare Professionals: Iressa (gefitinib).Fehrenbacher L. A Phase II, multicenter, randomized clinical trial to evaluate the efficacy and... Read more »Images
Related News
Fighting HIV
August 27, 2007DURHAM, N.C. (Ivanhoe Broadcast News) -- There are more than 1 million people living with HIV right now in the United States. Last year, nearly... Read summary »
Drug Linked to Birth Defects
August 04, 2008(Ivanhoe Newswire) Women who take epilepsy drugs while they're pregnant may be putting their children's health at risk. New research from Ireland... Read summary »
New Alzheimer's Breakthrough
May 05, 2008WASHINGTON (Ivanhoe Broadcast News) -- Most days, you'll find Frances Goldstein at her easel. "I like to paint ... a lot," she says. Jacobo, her... Read summary »
Off-Label Prescriptions
November 13, 2008(Ivanhoe Newswire) -- When your doctor prescribes a medication, you just assume it's been fully vetted by the U.S. Food and Drug Administration... Read summary »
Stopping Cancer Regrowth
September 11, 2008(Ivanhoe Newswire) -- Researchers are learning more about why some cancers regrow after initially responding to chemotherapy, and what can be done to... Read summary »
- Privacy Policy: Updated as of April 1, 2009|
- Service Terms and Agreement|
- Advertising Policy|
- Contact Us|
- About Us|
- RSS Feed|
- Site Map|
- How to Use This Site
By using this service, you accept our Terms of Use. Please read them. The consumer health information on SchizophreniaConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.
 | We comply with the HONcode standard for trustworthy health information: verify here. |
